Movatterモバイル変換

[0]ホーム

Пређи на садржај

LHCGR

Уреди везе

С Википедије, слободне енциклопедије

Luteinizirajući hormon/horiogonadotropinski receptor

Identifikatori

Simboli

LHCGR; LHR; LCGR; LGR2; hLHR

Vanjski ID

OMIM: 152790MGI: 96783HomoloGene: 37276IUPHAR:LHGeneCards:LHCGR Gene

Ontologija gena
Molekularna funkcija	•receptorska aktivnost •aktivnost lutropin/horiogonadotropinskog receptora
Celularna komponenta	•endozom •ćelijska membrana •integralno sa ćelijskom membranom
Biološki proces	•prenos signala •G-protein signalizacija, spregnuta sa cikličnim nukleotidnim sekundarnim glasnikom •razvoj gonade muškaraca •razvoj muških genitalija

Pregled RNK izražavanja

podaci

Ortolozi

Vrsta

Čovek

Miš

RefSeq (mRNA)

RefSeq (protein)

Lokacija (UCSC)

Chr 2:
48.77 - 48.84 Mb

Chr 17:
88.65 - 88.7 Mb

PubMed pretraga

[1]

[2]

LHCGR,luteinizirajući hormon/horiogonadotropinski receptor,lutropin/horiogonadotropinski receptor (LCGR) ilireceptor luteinizirajućeg hormona (LHR), jetransmembranski receptor nađen ujajnicima,testisima i ekstragonodalnim organima kao što jematerica. Ovaj receptor interaguje saluteinizirajućim hormonom (LH) i horionskim gonadotropinima (kao što jehCG kod čoveka). On je član familijeG protein-spregnutih receptora. Njegova aktivacija je neophodna za funkcionisanje hormona tokom reprodukcije.

LHCGR gen

[уреди |уреди извор]

LHCGRgen je nađen nahromozomu 2 p21 kod ljudi, blizo genaFSH receptora. On se sastoji od 70 kbp (versus 54 kpb zaFSHR).^[1] Gen je sličan genima FSH i TSH receptora.

Struktura receptora

[уреди |уреди извор]

LHCGR se sastoji od 674 aminokiselina i ima molekulsku masu od oko 85–95kDa u zavisnosti od stepena glikozilacije.^[2]

LHCGR abnormalnosti

[уреди |уреди извор]

Mutacije koje dovode do gubitka funkcije ovog receptora mogu da dovedu doneplodnosti kod žena. Opsežna inaktivacija može da uzrokujepseudohermafroditizam muškaraca, zbog odsustva responsa fetalnih Leidigovih ćelija i stoga indukuje maskulinizacije.^[3] Inaktivacija manje jačine može da dovede dohipospadije ili do razvojamikropenisa.^[2]

Istorija

[уреди |уреди извор]

Alfred G. Gilman iMartin Rodbel su nagrađeniNobelovom nagradom za fiziologiju ili medicinu 1994. za otkriće G proteinskog sistema.

Interakcije

[уреди |уреди извор]

Za luteinizirajući hormon/horiogonadotropinski receptor dainteraguje saGIPC1.^[4]

Reference

[уреди |уреди извор]

^Simoni M, Gromoll J, Nieschlag E (1997). „The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology”.Endocr. Rev.18 (6): 739—73.PMID 9408742.doi:10.1210/er.18.6.739.
^^а ^бAscoli M, Fanelli F, Segaloff DL (2002). „The lutropin/choriogonadotropin receptor, a 2002 perspective”.Endocr. Rev.23 (2): 141—74.PMID 11943741.doi:10.1210/er.23.2.141.
^Wu SM, Chan WY (1999). „Male pseudohermaphroditism due to inactivating luteinizing hormone receptor mutations”.Arch. Med. Res.30 (6): 495—500.PMID 10714363.doi:10.1016/S0188-4409(99)00074-0.
^Hirakawa, Takashi; Galet Colette; et al. (2003). „GIPC binds to the human lutropin receptor (hLHR) through an unusual PDZ domain binding motif, and it regulates the sorting of the internalized human choriogonadotropin and the density of cell surface hLHR”.J. Biol. Chem. United States.278 (49): 49348—57.ISSN 0021-9258.PMID 14507927.doi:10.1074/jbc.M306557200. Проверите вредност парамет(а)ра за датум:|date= (помоћ)

Literatura

[уреди |уреди извор]

Ji TH, Ryu KS, Gilchrist R, Ji I (1997). „Interaction, signal generation, signal divergence, and signal transduction of LH/CG and the receptor.”.Recent Prog. Horm. Res.52: 431—53; discussion 454.PMID 9238862.
Dufau ML (1998).„The luteinizing hormone receptor.”.Annu. Rev. Physiol.60: 461—96.PMID 9558473.doi:10.1146/annurev.physiol.60.1.461.
Ascoli M, Fanelli F, Segaloff DL (2002). „The lutropin/choriogonadotropin receptor, a 2002 perspective.”.Endocr. Rev.23 (2): 141—74.PMID 11943741.doi:10.1210/er.23.2.141.
Amsterdam A; Hanoch T; Dantes A; et al. (2003). „Mechanisms of gonadotropin desensitization.”.Mol. Cell. Endocrinol.187 (1-2): 69—74.PMID 11988313.doi:10.1016/S0303-7207(01)00701-8.
Fanelli F, Puett D (2003). „Structural aspects of luteinizing hormone receptor: information from molecular modeling and mutagenesis.”.Endocrine.18 (3): 285—93.PMID 12450321.doi:10.1385/ENDO:18:3:285.
Latronico AC, Segaloff DL (2007).„Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor.”.Mol. Cell. Endocrinol. 260-262: 287—93.PMC 1785107 .PMID 17055147.doi:10.1016/j.mce.2005.11.053.
Nagayama Y; Russo D; Wadsworth HL; et al. (1991).„Eleven amino acids (Lys-201 to Lys-211) and 9 amino acids (Gly-222 to Leu-230) in the human thyrotropin receptor are involved in ligand binding.”.J. Biol. Chem.266 (23): 14926—30.PMID 1651314.
Jia XC; Oikawa M; Bo M; et al. (1991). „Expression of human luteinizing hormone (LH) receptor: interaction with LH and chorionic gonadotropin from human but not equine, rat, and ovine species.”.Mol. Endocrinol.5 (6): 759—68.PMID 1922095.doi:10.1210/mend-5-6-759.
Minegishi T; Nakamura K; Takakura Y; et al. (1990). „Cloning and sequencing of human LH/hCG receptor cDNA.”.Biochem. Biophys. Res. Commun.172 (3): 1049—54.PMID 2244890.doi:10.1016/0006-291X(90)91552-4.
Rousseau-Merck MF; Misrahi M; Atger M; et al. (1991). „Localization of the human luteinizing hormone/choriogonadotropin receptor gene (LHCGR) to chromosome 2p21.”.Cytogenet. Cell Genet.54 (1-2): 77—9.PMID 2249480.doi:10.1159/000132962.
Xie YB, Wang H, Segaloff DL (1991). „Extracellular domain of lutropin/choriogonadotropin receptor expressed in transfected cells binds choriogonadotropin with high affinity.”.J. Biol. Chem.265 (35): 21411—4.PMID 2254302.
Frazier AL; Robbins LS; Stork PJ; et al. (1991). „Isolation of TSH and LH/CG receptor cDNAs from human thyroid: regulation by tissue specific splicing.”.Mol. Endocrinol.4 (8): 1264—76.PMID 2293030.doi:10.1210/mend-4-8-1264.
Keutmann HT; Charlesworth MC; Mason KA; et al. (1987).„A receptor-binding region in human choriogonadotropin/lutropin beta subunit.”.Proc. Natl. Acad. Sci. U.S.A.84 (7): 2038—42.PMC 304579 .PMID 3470775.doi:10.1073/pnas.84.7.2038.
Atger M; Misrahi M; Sar S; et al. (1995).„Structure of the human luteinizing hormone-choriogonadotropin receptor gene: unusual promoter and 5' non-coding regions.”.Mol. Cell. Endocrinol.111 (2): 113—23.PMID 7556872.doi:10.1016/0303-7207(95)03557-N.
Latronico AC; Anasti J; Arnhold IJ; et al. (1995). „A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty.”.J. Clin. Endocrinol. Metab.80 (8): 2490—4.PMID 7629248.doi:10.1210/jc.80.8.2490.
Shenker A; Laue L; Kosugi S; et al. (1993).„A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty.”.Nature.365 (6447): 652—4.PMID 7692306.doi:10.1038/365652a0.
Yano K; Saji M; Hidaka A; et al. (1995). „A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty.”.J. Clin. Endocrinol. Metab.80 (4): 1162—8.PMID 7714085.doi:10.1210/jc.80.4.1162.
Kremer H; Kraaij R; Toledo SP; et al. (1995). „Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene.”.Nat. Genet.9 (2): 160—4.PMID 7719343.doi:10.1038/ng0295-160.
Kosugi S; Van Dop C; Geffner ME; et al. (1995). „Characterization of heterogeneous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty.”.Hum. Mol. Genet.4 (2): 183—8.PMID 7757065.doi:10.1093/hmg/4.2.183.
Kremer H; Mariman E; Otten BJ; et al. (1994). „Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty.”.Hum. Mol. Genet.2 (11): 1779—83.PMID 8281137.doi:10.1093/hmg/2.11.1779.

Spoljašnje veze

[уреди |уреди извор]

„Glycoprotein Hormone Receptors: LH”.IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Архивирано изоригинала 18. 01. 2021. г.
GRIS: Glycoprotein-hormone Receptor Information System
LH-hCG+Receptors наUS National Library of Medicine Medical Subject Headings (MeSH)

Transmembranski receptor:receptori spregnuti s G proteinom

Klasa A:Rodopsinu slični

Neurotransmiter

Adrenergički	α1 (A,B,D) • α2 (A,B,C) • β1 • β2 • β3
Purinski	Adenozinski (A1,A2A,A2B,A3) • P2Y (1,2,4,5,6,8,9,10,11,12,13,14)
Serotoninski	(svi osim 5-HT3)5-HT1 (A,B,D,E,F) • 5-HT2 (A,B,C) • 5-HT (4,5A,6,7)
Drugi	Acetilholin (M1,M2,M3,M4,M5) • Dopamin (D1,D2,D3,D4,D5) • Histamin (H1,H2,H3,H4) • Melatonin (1A,1B,1C) • TAAR (1,2,3,5,6,8,9)

Metaboliti i
signalni molekuli

Eikozanoidni	CysLT (1,2) • LTB4 (1,2) • FPRL1 • OXE • Prostaglandin (DP (1,2),EP (1,2,3,4),FP) • Prostaciklin • Tromboksan
Drugi	Žučna kiselina • Kanabinoidni (CB1,CB2,GPR (18,55,119)) • EBI2 • Estrogen • Slobodna masna kiselina (1,2,3,4) • Laktat • Lizofosfatidna kiselina (1,2,3,4,5,6) • Lizofosfolipid (1,2,3,4,5,6,7,8) • Niacin (1,2) • Oksoglutarat • PAF • Sfingozin-1-fosfat (1,2,3,4,5) • Sukcinat

Peptid

Neuropeptidni

B/W (1,2) • FF (1,2) • S • Y (1,2,4,5) • Neuromedin (B,U (1,2)) • Neurotenzin (1,2)

Drugi

Anafilatoksin (C3a,C5a) • Angiotenzin (1,2) • Apelin • Bombezin (BRS3,GRPR,NMBR) • Bradikinin (B1,B2) • Hemokin • Holecistokinin (A,B) • Endotelin (A,B) • Formil peptid (1,2,3) • FSH • Galanin (1,2,3) • GHB receptor • Gonadotropin-oslobađajući hormon (1,2) • Grelin • Kispeptin • Luteinizirajući hormon/horiogonadotropin • MAS (1,1L,D,E,F,G,X1,X2,X3,X4) • Melanokortin (1,2,3,4,5) • MCHR (1,2) • Motilin • Opioidni (δ,κ,μ,Nociceptin &ζ, ali neσ) • Oreksin (1,2) • Oksitocin • Prokineticin (1,2) • Prolaktin-oslobađajući peptid • Relaksin (1,2,3,4) • Somatostatin (1,2,3,4,5) • Tahikinin (1,2,3) • Tirotropin • Tirotropin-oslobađajući hormon • Urotenzin-II • Vazopresin (1A,1B,2)

Razno

Orfan	GPR (1,3,4,6,12,15,17,18,19,20,21,22,23,25,26,27,31,32,33,34,35,37,39,42,44,45,50,52,55,61,62,63,65,68,75,77,78,81,82,83,84,85,87,88,92,101,103,109A,109B,119,120,132,135,137B,139,141,142,146,148,149,150,151,152,153,160,161,162,171,173,174,176,177,182,183)
Drugi	Adrenomedulin • Mirisni • Opsin (3,4,5,1LW,1MW,1SW,RGR,RRH) • Proteazom-aktivirani (1,2,3,4) • SREB (1,2,3)

Klasa B:Sekretinu slični

Orfan	GPR (56,64,97,98,110,111,112,113,114,115,116,123,124,125,126,128,133,143,144,155,157)
Drugi	Moždano specifični angiogenezni inhibitor (1,2,3) • Kadherin (1,2,3) • Kalcitonin • CALCRL • CD97 • Kortikotropin-oslobađajući hormon (1,2) • EMR (1,2,3) • Glukagon (GR,GIPR,GLP1R,GLP2R) • Hormon rasta • PACAPR1 • GPR • Latrofilin (1,2,3,ELTD1) • Metuzalemski protein • Paratiroidni hormon (1,2) • Sekretin • Vazoaktivni intestinalni peptid (1,2)

Klasa C:Metabotropni
glutamat /feromon

Ukus	TAS1R (1,2,3) • TAS2R (1,3,4,5,8,9,10,12,13,14,16,19,20,30,31,38,39,40,41,42,43,45,46,50)
Drugi	Kalcijum-detektujući receptor • GABA B (1,2) • Glutamatni receptor (Metabotropni glutamat (1,2,3,4,5,6,7,8)) • GPRC6A • GPR (156,158,179) • RAIG (1,2,3,4) • VNR (1,2,3,5)

Klasa F:
Frizzled /Zaglađeni

Uvojiti	Frizzled (1,2,3,4,5,6,7,8,9,10)
Zaglađeni	Zaglađeni

Neuropeptidni receptori

Hormonski receptori

Hipotalamusni	CRH –FSH –LHRH –TRH –Somatostatin
Hipofizni	Vazopresin (1A,1B,2) –Oksitocin –LHCG –Tip I citokinski receptor (GH,Prolaktin) –TSH
Drugi	Atrijalni natriuretski faktor (NPR1,NPR2,NPR3) –Kalcitonin –Holecistokinin (A,B) –VIP

Opioidni receptori

Delta –Kapa –Mi –Sigma (1,2) –Nociceptin

Drugi neuropeptidni receptori

Angiotenzin –Bradikinin (B1,B2) /Tahikinin (TACR1) –Kalcitoninu sličan –Galanin –GPCR neuropeptid (B/W,FF,S,Y) –Neurotenzin

Преузето из „https://sr.wikipedia.org/w/index.php?title=LHCGR&oldid=30646913”

Категорије:

Сакривене категорије:

[8]ページ先頭